Roche Warns Of Bigger Negative Impact From COVID-19 And Biosimilars

Dog in headwind at the stony beach
Roche faced headwinds from COVID-19 and biosimilars in H1 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Business